Minisymposium on Ambient pressure x-ray photoelectron spectroscopy at MAX IV
On Monday, 30 May 2016, a minisymposium on “Ambient pressure x-ray photoelectron spectroscopy at MAX IV” was held at the MAX IV Laboratory. The minisymposium had the aim to provide an opportunity to discuss the status of the SPECIES and HIPPIE beamlines at MAX IV as well as current and future science with Ambient pressure x-ray photoelectron spectroscopy (APXPS). Please find the programme of the minisymposium below. Presentations available to us will soon be published here.
We would like to thank all speakers for their excellent contributions – due to these contributions the Ambient pressure x-ray photoelectron spectroscopy became a very inspiring and successful event!
|13.00||Joachim Schnadt, MAX IV Laboratory||Introduction & Overview|
|13.15||Samuli Urpelainen, MAX IV Laboratory||The SPECIES beamline|
|13.35||Jan Knudsen, MAX IV Laboratory||The HIPPIE beamline|
|14.00||Håkan Rensmo, Uppsala University||Studies on Energy and Enviornmental Applications using X-ray-based Spectroscopy|
|14.20||Rainer Timm, Lund University||Unexpected surface chemistry during atomic layer deposition of high-k oxides revealed by time-resolved XPS|
|14.40||Harri Ali-Löytty||X-ray photoelectron spectroscopy of electrochemical interfaces for solar fuel production|
|15.30||Peter Amann, Stockholm University||Ambient Pressure XPS at Stockholm University|
|15.50||Jeppe Vang Lauritsen, Aarhus University||Ambient pressure studies of sulfide catalysts|
|16.10||Jens Uhlig, Lund University||HPXPS for electron dynamics|
|16.30||Dmytro Orlov||(Bio-)Degradation of Mg alloys as a hot subject for ambient pressure XPS studies|
|17.00||Visit of the HIPPIE and SPECIES beamlines|
Structures of several clinically relevant NUDT15 variants are discovered – paving the way for better cancer treatments
NUDT15 bound to TH7755. Credit: Emma Scaletti Recent research by a group of researchers from Sweden, the US, and the UK successfully developed a specific NUDT15 inhibitor, TH7755, that helped the group to obtain structures of clinically relevant NUDT15 variants: Arg139Cys, Arg139His, Val18Ile, and V18_V19insGlyVal. These insights allow further understandings of the structural basis of